How does psychological resilience "buffer" against depression in prostate cancer patients following diagnosis?

Vicki Bitsika, Christopher Sharpley, Addie Wooten, David R H Christie

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Abstract

Objective
To (a) investigate the nature of psychological resilience among two samples of prostate cancer patients via factor analysis, (b) determine the effects of the derived factors upon depression in those prostate cancer patients, and (c) plot the trajectory of those effects over the first 5 years following diagnosis.

Methods
Postal surveys of 425 PCa patients were collected from two sites: 189 PCa patients at site 1 and 236 at site 2. Background data plus responses to depression and resilience scales were collected.

Results
Total resilience score was a significant buffer against depression across both sites. Resilience had different factor structures across sites, but only one (common) factor significantly (inversely) predicted depression. Within that factor, only some specific items significantly inversely predicted depression scores, suggesting a very focussed relationship between resilience and depression. Variability in that inverse relationship between resilience responses and depression was noted over time since diagnosis, with peaks in the correlation between the variables during the first 6 months, at 24 and 60 months.

Conclusions
Measures of resilience may be used to screen PCa patients who are at-risk of depression. These patients might benefit from resilience training to enhance their ability to cope effectively with the stress of their diagnosis and treatment. A focus upon specific aspects of overall resilience may be of further benefit in both these processes. These data argue strongly for focussed psychological interventions at various specific periods following a diagnosis of PCa.
Original languageEnglish
Pages (from-to)56-56
Number of pages1
JournalBJU International
Volume112
DOIs
Publication statusPublished - Aug 2013

Cite this

Bitsika, Vicki ; Sharpley, Christopher ; Wooten, Addie ; Christie, David R H. / How does psychological resilience "buffer" against depression in prostate cancer patients following diagnosis?. In: BJU International. 2013 ; Vol. 112. pp. 56-56.
@article{d4451711c0ad45fe882e5a1262e8cb71,
title = "How does psychological resilience {"}buffer{"} against depression in prostate cancer patients following diagnosis?",
abstract = "ObjectiveTo (a) investigate the nature of psychological resilience among two samples of prostate cancer patients via factor analysis, (b) determine the effects of the derived factors upon depression in those prostate cancer patients, and (c) plot the trajectory of those effects over the first 5 years following diagnosis.MethodsPostal surveys of 425 PCa patients were collected from two sites: 189 PCa patients at site 1 and 236 at site 2. Background data plus responses to depression and resilience scales were collected.ResultsTotal resilience score was a significant buffer against depression across both sites. Resilience had different factor structures across sites, but only one (common) factor significantly (inversely) predicted depression. Within that factor, only some specific items significantly inversely predicted depression scores, suggesting a very focussed relationship between resilience and depression. Variability in that inverse relationship between resilience responses and depression was noted over time since diagnosis, with peaks in the correlation between the variables during the first 6 months, at 24 and 60 months.ConclusionsMeasures of resilience may be used to screen PCa patients who are at-risk of depression. These patients might benefit from resilience training to enhance their ability to cope effectively with the stress of their diagnosis and treatment. A focus upon specific aspects of overall resilience may be of further benefit in both these processes. These data argue strongly for focussed psychological interventions at various specific periods following a diagnosis of PCa.",
author = "Vicki Bitsika and Christopher Sharpley and Addie Wooten and Christie, {David R H}",
year = "2013",
month = "8",
doi = "10.1111/bju.12294",
language = "English",
volume = "112",
pages = "56--56",
journal = "British Journal of Urology",
issn = "1464-410X",
publisher = "Wiley-Blackwell",

}

How does psychological resilience "buffer" against depression in prostate cancer patients following diagnosis? / Bitsika, Vicki; Sharpley, Christopher; Wooten, Addie; Christie, David R H.

In: BJU International, Vol. 112, 08.2013, p. 56-56.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

TY - JOUR

T1 - How does psychological resilience "buffer" against depression in prostate cancer patients following diagnosis?

AU - Bitsika, Vicki

AU - Sharpley, Christopher

AU - Wooten, Addie

AU - Christie, David R H

PY - 2013/8

Y1 - 2013/8

N2 - ObjectiveTo (a) investigate the nature of psychological resilience among two samples of prostate cancer patients via factor analysis, (b) determine the effects of the derived factors upon depression in those prostate cancer patients, and (c) plot the trajectory of those effects over the first 5 years following diagnosis.MethodsPostal surveys of 425 PCa patients were collected from two sites: 189 PCa patients at site 1 and 236 at site 2. Background data plus responses to depression and resilience scales were collected.ResultsTotal resilience score was a significant buffer against depression across both sites. Resilience had different factor structures across sites, but only one (common) factor significantly (inversely) predicted depression. Within that factor, only some specific items significantly inversely predicted depression scores, suggesting a very focussed relationship between resilience and depression. Variability in that inverse relationship between resilience responses and depression was noted over time since diagnosis, with peaks in the correlation between the variables during the first 6 months, at 24 and 60 months.ConclusionsMeasures of resilience may be used to screen PCa patients who are at-risk of depression. These patients might benefit from resilience training to enhance their ability to cope effectively with the stress of their diagnosis and treatment. A focus upon specific aspects of overall resilience may be of further benefit in both these processes. These data argue strongly for focussed psychological interventions at various specific periods following a diagnosis of PCa.

AB - ObjectiveTo (a) investigate the nature of psychological resilience among two samples of prostate cancer patients via factor analysis, (b) determine the effects of the derived factors upon depression in those prostate cancer patients, and (c) plot the trajectory of those effects over the first 5 years following diagnosis.MethodsPostal surveys of 425 PCa patients were collected from two sites: 189 PCa patients at site 1 and 236 at site 2. Background data plus responses to depression and resilience scales were collected.ResultsTotal resilience score was a significant buffer against depression across both sites. Resilience had different factor structures across sites, but only one (common) factor significantly (inversely) predicted depression. Within that factor, only some specific items significantly inversely predicted depression scores, suggesting a very focussed relationship between resilience and depression. Variability in that inverse relationship between resilience responses and depression was noted over time since diagnosis, with peaks in the correlation between the variables during the first 6 months, at 24 and 60 months.ConclusionsMeasures of resilience may be used to screen PCa patients who are at-risk of depression. These patients might benefit from resilience training to enhance their ability to cope effectively with the stress of their diagnosis and treatment. A focus upon specific aspects of overall resilience may be of further benefit in both these processes. These data argue strongly for focussed psychological interventions at various specific periods following a diagnosis of PCa.

U2 - 10.1111/bju.12294

DO - 10.1111/bju.12294

M3 - Meeting Abstract

VL - 112

SP - 56

EP - 56

JO - British Journal of Urology

JF - British Journal of Urology

SN - 1464-410X

ER -